350 related articles for article (PubMed ID: 25337143)
1. Role of MicroRNAs in Hepatocellular Carcinoma.
Zhu Z; Zhang X; Wang G; Zheng H
Hepat Mon; 2014 Aug; 14(8):e18672. PubMed ID: 25337143
[TBL] [Abstract][Full Text] [Related]
2. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
Chen E; Xu X; Liu R; Liu T
Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in Hepatobiliary and Pancreatic Cancers.
Saito Y; Suzuki H; Matsuura M; Sato A; Kasai Y; Yamada K; Saito H; Hibi T
Front Genet; 2011; 2():66. PubMed ID: 22303361
[TBL] [Abstract][Full Text] [Related]
4. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
5. The role of microRNAs in gallbladder cancer.
Yang G; Zhang L; Li R; Wang L
Mol Clin Oncol; 2016 Jul; 5(1):7-13. PubMed ID: 27330755
[TBL] [Abstract][Full Text] [Related]
6. The role of miRNAs in cutaneous squamous cell carcinoma.
Yu X; Li Z
J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.
Fang Y; Zhang L; Li Z; Li Y; Huang C; Lu X
Int Rev Cell Mol Biol; 2017; 333():1-49. PubMed ID: 28729023
[TBL] [Abstract][Full Text] [Related]
8. Complex interactions between microRNAs and hepatitis B/C viruses.
Fan HX; Tang H
World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
[TBL] [Abstract][Full Text] [Related]
9. Oncomirs - microRNAs with a role in cancer.
Esquela-Kerscher A; Slack FJ
Nat Rev Cancer; 2006 Apr; 6(4):259-69. PubMed ID: 16557279
[TBL] [Abstract][Full Text] [Related]
10. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
[TBL] [Abstract][Full Text] [Related]
11. Bone Metastasis-Related MicroRNAs: New Targets for Treatment?
Zhao Q; Luo F; Ma J; Yu X
Curr Cancer Drug Targets; 2015; 15(8):716-25. PubMed ID: 26119014
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
Giordano S; Columbano A
Hepatology; 2013 Feb; 57(2):840-7. PubMed ID: 23081718
[TBL] [Abstract][Full Text] [Related]
13. Role of miRNA sponges in hepatocellular carcinoma.
Li D; Zhang J; Li J
Clin Chim Acta; 2020 Jan; 500():10-19. PubMed ID: 31604064
[TBL] [Abstract][Full Text] [Related]
14. The role of microRNAs in the adrenocortical carcinomas.
Yu X; Li Z
Tumour Biol; 2016 Feb; 37(2):1515-9. PubMed ID: 26671553
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs involved with hepatocellular carcinoma (Review).
Mao B; Wang G
Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.
Ge Y; Yan X; Jin Y; Yang X; Yu X; Zhou L; Han S; Yuan Q; Yang M
PLoS Genet; 2015 Dec; 11(12):e1005726. PubMed ID: 26710269
[TBL] [Abstract][Full Text] [Related]
17. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
George J; Patel T
Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
[TBL] [Abstract][Full Text] [Related]
18. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression.
Chu R; Mo G; Duan Z; Huang M; Chang J; Li X; Liu P
Cell Commun Signal; 2014 Jul; 12():45. PubMed ID: 25012758
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.
Hung CH; Chiu YC; Chen CH; Hu TH
Biomed Res Int; 2014; 2014():486407. PubMed ID: 24800233
[TBL] [Abstract][Full Text] [Related]
20. The Role of MicroRNAs in Hepatocellular Carcinoma.
Xu X; Tao Y; Shan L; Chen R; Jiang H; Qian Z; Cai F; Ma L; Yu Y
J Cancer; 2018; 9(19):3557-3569. PubMed ID: 30310513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
